Synopsis:
This study evaluated the clinical effects of radiofrequency ablation (RFA) for transarterial chemoembolization (TACE) postoperative residual tumor in liver cancer. RFA can efficiently clear the TACE postoperative residual tumor and prolong both progression-free survival (PFS) and overall survival (OS).